TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
24 hedge funds and large institutions have $4.62M invested in Trillium Therapeutics Inc. in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$561K | |
| 2 | +$163K | |
| 3 | +$73K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$65K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$24.2K |
Top Sellers
| 1 | -$298K | |
| 2 | -$40K | |
| 3 | -$19K | |
| 4 |
Jane Street
New York
|
-$1.35K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$396 |